Insider Trading & Ownership of Column Group IV GP, LP

Location
San Francisco, CA
Signature
/s/ The Column Group IV GP, LP, /s/ James Evangelista, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Column Group IV GP, LP and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Column Group IV GP, LP has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value is not available.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Eikon Therapeutics, Inc. ().
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Column Group IV GP, LP

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
EIKN Eikon Therapeutics, Inc. 10%+ Owner 06 Feb 2026

Insider Transactions Reported by Column Group IV GP, LP:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored